Trade

with

Idexx Laboratories
(NASDAQ: IDXX)
AdChoices
124.74
+0.34
+0.27%
After Hours :
124.72
-0.02
-0.02%

Open

123.55

Previous Close

124.40

Volume (Avg)

559.21k (510.72k)

Day's Range

123.30-125.38

52Wk Range

101.33-140.00

Market Cap.

6.27B

Dividend Rate ( Yield )

-

Beta

0.77

Shares Outstanding

50.27M

P/E Ratio (EPS)

34.01 (3.67)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Underperform
    • Revenue

    • 1.38B

    • Net Income

    • 187.80M

    • Market Cap.

    • 6.27B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 13.36

    • PEG (Price/Earnings Growth) Ratio

    • 2.29

    • Beta

    • 0.77

    • Forward P/E

    • 28.57

    • Price/Sales

    • 4.53

    • Price/Book Value

    • 13.81

    • Price/Cash flow

    • 25.25

      • EBITDA

      • 323.24M

      • Return on Capital %

      • 15.75

      • Return on Equity %

      • 38.46

      • Return on Assets %

      • 15.75

      • Book Value/Share

      • 9.01

      • Shares Outstanding

      • 50.27M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Underperform
        • 1 Year Price Target

        • 117.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 4.55

        • Cashflow Estimate

        • 5.51

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.60

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 5.30

          • -5.55

          • Net Income

            Q/Q (last year)

          • 6.00

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 6.10

          • 47.82

          • Net Income

            5-Year Annual Average

          • 10.10

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 55.11

            • 42.70

            • Pre-Tax Margin

            • 18.92

            • 11.63

            • Net Profit Margin

            • 13.36

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 53.10

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 18.70

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 13.10

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.33

              • 0.62

              • Current Ratio

              • 1.17

              • 1.23

              • Quick Ratio

              • 0.79

              • 0.76

              • Interest Coverage

              • 30.96

              • 5.98

              • Leverage Ratio

              • 2.83

              • 2.16

              • Book Value/Share

              • 9.01

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 33.90

                • 32.47

                • P/E Ratio 5-Year High

                • 38.17

                • 325.07

                • P/E Ratio 5-Year Low

                • 13.37

                • 154.73

                • Price/Sales Ratio

                • 4.53

                • 2.26

                • Price/Book Value

                • 13.81

                • 2.95

                • Price/Cash Flow Ratio

                • 25.25

                • 18.55

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 38.46

                    (28.70)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 15.75

                    (16.30)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 20.90

                    (20.70)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 33.82k

                  • 17.17k

                  • Inventory Turnover

                  • 4.52

                  • 5.07

                  • Asset Turnover

                  • 1.18

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  266.76M
                  Operating Margin
                  19.37
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  25.25
                  Ownership

                  Institutional Ownership

                  96.77%

                  Top 10 Institutions

                  58.06%

                  Mutual Fund Ownership

                  55.93%

                  Float

                  72.43%

                  5% / Insider Ownership

                  1.64%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • T. Rowe Price Mid Cap Growth Fund

                  •  

                    2,125,000

                  • 0.00

                  • 4.21

                  • Sequoia Fund

                  •  

                    1,974,648

                  • -0.09

                  • 3.91

                  • Neuberger Berman Genesis Fund

                  •  

                    1,439,262

                  • -2.55

                  • 2.85

                  • T. Rowe Price Growth Stock Fund

                  •  

                    1,230,900

                  • -27.26

                  • 2.44

                  • T. Rowe Price New Horizons Fund

                  •  

                    1,155,100

                  • 11.41

                  • 2.29

                  • Baron Growth Fund

                  •  

                    900,000

                  • 0.00

                  • 1.79

                  • Vanguard Mid-Cap Index Fund

                  •  

                    860,054

                  • -0.95

                  • 1.71

                  • Vanguard Total Stock Mkt Idx

                  •  

                    837,233

                  • 0.43

                  • 1.67

                  • Baron Asset Fund

                  •  

                    825,000

                  • 0.00

                  • 1.64

                  • Royce Premier Fund

                  •  

                    712,300

                  • -8.35

                  • 1.42

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • T. Rowe Price Associates, Inc.

                  •  

                    7,714,670

                  • -7.24%

                  • 15.27

                  • Ruane, Cunniff & Goldfarb Inc

                  •  

                    5,238,390

                  • -0.27%

                  • 10.37

                  • BAMCO Inc

                  •  

                    3,692,912

                  • -0.99%

                  • 7.31

                  • Vanguard Group, Inc.

                  •  

                    2,910,701

                  • +1.89%

                  • 5.76

                  • Blair William & Co

                  •  

                    2,821,796

                  • -19.40%

                  • 5.59

                  • Neuberger Berman LLC

                  •  

                    1,961,655

                  • -3.44%

                  • 3.88

                  • BlackRock Fund Advisors

                  •  

                    1,515,044

                  • +3.00%

                  • 3.00

                  • State Street Corp

                  •  

                    1,347,022

                  • -2.87%

                  • 2.67

                  • Royce & Associates, LLC

                  •  

                    1,203,911

                  • 0.00%

                  • 2.38

                  • Atlanta Capital Management Company,LLC

                  •  

                    922,072

                  • +0.11%

                  • 1.83

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Aggressive Growth

                  Style

                  Mid Growth

                  Idexx Laboratories, a Delaware corporation, was incorporated in 1983. The Company develops, manufactures and distributes products and provide services for the companion animal veterinary, livestock and poultry, water testing and dair...morey markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its product and services includes: Point-of-care veterinary diagnostic products, comprising instruments and consumables, and rapid assays; Veterinary reference laboratory diagnostic and consulting services used by veterinarians; Practice management systems and services and digital radiography systems used by veterinarians; Biological materials testing and laboratory diagnostic instruments and services used by the biomedical res...moreearch community; Diagnostic and health-monitoring products for livestock and poultry; Products that test water for certain microbiological contaminants; Products that test milk for antibiotic residues and other contaminants; and Point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market. Its operations are segmented into three namely - CAG, Water, LPD, and Other. CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the bioresearch market, primarily related to diagnostics and information management. Water segment develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water. LPD segment develops, designs, manufactures and distributes diagnostic tests and related instrumentation that are used to detect a wide range of diseases and to monitor health status in livestock and poultry, as well as products that ensure the quality and safety of milk and food. The other smaller operating segments are comprised of Dairy and OPTI Medical operating segments and a product line and out-licensing arrangements remaining from pharmaceutical business. Dairy segment develops, designs, manufactures and distributes products to detect contaminants in milk. OPTI Medical develops, designs, manufactures, and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market. Further, OPTI Medical manufactures VetStat Electrolyte and Blood Gas Analyzer and electrolyte consumables used with its Catalyst Dx analyzer. The Company competes with many companies ranging from large human pharmaceutical and medical diagnostics companies to small businesses focused on animal health. Its companion animal veterinary diagnostic products and services compete with both reference laboratory service and in-clinic product providers. Its trademarks include: 4Dx®, Catalyst Dx®, Catalyst One™, Coag Dx™, Colilert®, Colisure®, Cornerstone®, DVMAX®, Enterolert®, EquiView®, EquiView PACS®, Feline Triple®, Filta-Max®, Filta-Max xpress®, IDEXX I-Vision CR®, IDEXX I-Vision DR®, IDEXX I-Vision Mobile™, IDEXX ImageBank™ , IDEXX-PACS™, IDEXX VetLab®, IDEXX VPM™, LaserCyte®, LaserCyte Dx™, Navigator™, OPTI®, OPTI LION™, PetChek®, PetDetect®, Pet Health Network®, Practice Profile™, ProCyte Dx®, Pseudalert®, Quanti-Tray®, SimPlate®, SmartService™, SNAP®, SNAPduo®, SNAP Pro®, SNAP cPL™ , SNAP fPL™, SNAPshot Dx®, VetAutoread™, VetConnect®, VetLab UA™, VetLINK®, VetLyte®, VetStat®, VetTest® and VetVault®. Many of its products are subject to comprehensive regulation by U.S. and foreign regulatory agencies that relate to, among other things, product approvals, manufacturing, distribution, marketing and promotion, labeling, recordkeeping, testing, quality, storage and product disposal.lessless

                  Key People

                  Mr. Jonathan W. Ayers

                  CEO/Chairman of the Board/Director/President

                  Brian P. Mckeon

                  CFO/Chief Accounting Officer/Executive VP/Treasurer

                  Jeffrey A. Fiarman

                  Executive VP/General Counsel/Secretary

                  Dr. Johnny D. Powers, PhD

                  Executive VP

                  Dr. Michael J. Williams,PhD

                  Executive VP

                  • Idexx Laboratories

                  • One IDEXX Drive

                  • Westbrook, ME 04092

                  • USA.Map

                  • Phone: +1 207 556-0300

                  • Fax: +1 207 556-4346

                  • idexx.com

                  Incorporated

                  1983

                  Employees

                  5,700

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: